Vertex Pharmaceuticals Inc / Ma
2020 Q1 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/5/2026 | 166,111 | 0.5% | 366,341 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 147,450 | 0.4% | 376,495 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 174,240 | 0.5% | 391,376 | 6/30/2025 |
| 2025 Q1 | 9/17/2025 | 193,573 | 0.6% | 398,031 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 159,024 | 0.5% | 368,967 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 177,579 | 0.6% | 335,645 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 5,877 | 0.0% | 13,503 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 119,407 | 0.5% | 286,108 | 3/31/2024 |
| 2023 Q4 | 5/16/2024 | 82,856 | 0.4% | 203,632 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 64,551 | 0.4% | 185,630 | 9/30/2023 |
| 2023 Q2 | 7/24/2023 | 60,409 | 0.4% | 171,661 | 6/30/2023 |
| 2023 Q1 | 5/11/2023 | 54,021 | 0.3% | 171,457 | 3/31/2023 |
| 2022 Q4 | 1/24/2023 | 49,199 | 0.3% | 170,370 | 12/31/2022 |
| 2022 Q3 | 11/4/2022 | 2,338 | 0.0% | 8,075 | 9/30/2022 |
| 2022 Q2 | 7/22/2022 | 1,214 | 0.0% | 4,308 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 814 | 0.0% | 3,119 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 101 | 0.0% | 460 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 902 | 0.0% | 4,975 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 581 | 0.0% | 2,882 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 468 | 0.0% | 2,179 | 3/31/2021 |
| 2020 Q4 | 2/24/2021 | 3,840 | 0.0% | 16,248 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 2,234 | 0.0% | 8,396 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 1,793 | 0.0% | 6,176 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 1,672 | 0.0% | 7,027 | 3/31/2020 |